Fortunately, in May 2019, another GLP-1 drug, polyethylene glycol loxenatide, was launched, effectively alleviating this embarrassing situation
Sign Up For Our Newsletter MHM Aesthetics Medical Clinic 2024 | All rights Reserved.
For GLP-1 receptor agonist users, the cumulative incidence of treatment discontinuation was 23.6% (95% CI 23.2, 23.9) at 1 year and 38.5% (95% CI 38.2, 38.9) at 3 years, when using a grace period of 90 days
Hormonal fluctuations during the menstrual cycle can also affect tirzepatide tolerance
Joint pain patients typically feel the anti-inflammatory effect at 2 to 3 weeks, with structural support benefits accumulating at 4 to 6 weeks
Vitamin D receptors on hair follicle cells are directly involved in the anagen-to-catagen transition